Cerebrocostomandibular Syndrome
Description
Cerebro-costo-mandibular syndrome (CCMS) is characterized at birth by posterior rib gaps and orofacial anomalies reminiscent of Pierre Robin syndrome (see this term) that include palatal defects (short hard palate, absent soft palate, absent uvula), micrognathia and glossoptosis.
Clinical Features
Top most frequent phenotypes and symptoms related to Cerebrocostomandibular Syndrome
- Intellectual disability
- Global developmental delay
- Short stature
- Microcephaly
- Scoliosis
- Growth delay
- Failure to thrive
- Micrognathia
- Cleft palate
- Low-set ears
And another 62 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Cerebrocostomandibular Syndrome Is also known as rib gap defects with micrognathia.
Researches and researchers
Doctors, researchs, and experts related to Cerebrocostomandibular Syndrome extracted from public data.
Cerebrocostomandibular Syndrome Experts map
Current Researchs and researchers
-
CALGARY — Dr François BERNIER
Coordinator of expert centre - Investigator of research project
-
Institution/s:
— Alberta Children's Hospital -
Research area/topic::
Investigating the Effects of Mutation in the Spliceosomal Gene SNRPB in Cerebro-Costo-Mandibular Syndrome
-
Institution/s:
-
CALGARY — Dr Jillian PARBOOSINGH
Responsible for diagnostic tests - Investigator of research project - Director of laboratory
-
Institution/s:
— Alberta Health Services, Alberta Children's Hospital -
Research area/topic::
Investigating the Effects of Mutation in the Spliceosomal Gene SNRPB in Cerebro-Costo-Mandibular Syndrome
-
Institution/s:
Cerebrocostomandibular Syndrome Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Craniofacial Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
RUNX2, SALL1, SF3B4, SIX1, SIX5, SKI, SNRPB, TCF12, TCOF1, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, POLR1A, WDR19, EVC2, POLR1C, POLR1D , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
100 % |
Craniofacial Seq + Del/Dup Panel.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
RUNX2, SALL1, SF3B4, SIX1, SIX5, SKI, SNRPB, TCF12, TCOF1, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, POLR1A, WDR19, EVC2, POLR1C, POLR1D , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
100 % |
Craniofacial Seq Analysis.
By Division of Genomic Diagnostics The Children's Hospital of Philadelphia (United States).
RUNX2, SALL1, SF3B4, SIX1, SIX5, SKI, SNRPB, TCF12, TCOF1, TWIST1, ZIC1, IFT122, RAB23, ALX1, CD96, POLR1A, WDR19, EVC2, POLR1C, POLR1D , (...)
View the complete list with 22 more genes
Specificity
3 %
Genes
100 % |
CEREBROCOSTOMANDIBULAR SYNDROME.
By Laboratorio de Genetica Clinica SL (Spain).
SNRPB
Specificity
100 %
Genes
100 % |
You can get up to -4 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH ORPHANET OMIM Rare Disease Search EngineIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3 JUNCTIONAL EPIDERMOLYSIS BULLOSA INVERSA HEMOCHROMATOSIS, TYPE 4; HFE4 SPINAL MUSCULAR ATROPHY, TYPE III; SMA3 OPTIC ATROPHY 11; OPA11 NEUROECTODERMAL-ENDOCRINE SYNDROME